| Pharmaceutical active ingredients: |
| Dextromethorphan HydrobromideGuaifenesin |
| Available forms, composition and doses of Syracol CF: |
| N / A |
| Syracol CF medical category: |
| Human:AntitussivesCough and cold preparationsExpectorants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CA03 - GuaifenesinR05DA09 - Dextromethorphan |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Shire |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Safe Tussin | Dextromethorphan Hydrobromide; Guaifenesin | Kramer Laboratories |
| Scot-Tussin Senior Clear | Dextromethorphan Hydrobromide; Guaifenesin | Scot-Tussin Pharmacal |
| Siltussin DM | Dextromethorphan Hydrobromide; Guaifenesin | Silarx Pharmaceuticals |
| Su-Tuss DM | Dextromethorphan Hydrobromide; Guaifenesin | Cypress Pharmaceutical |
| Synacol CF | Dextromethorphan Hydrobromide; Guaifenesin | Shire |
| Syrup DM-E | Dextromethorphan Hydrobromide; Guaifenesin | E-Z-EM; Therapex |
| Teratos | Dextromethorphan Hydrobromide; Guaifenesin | Grupo Farma |
| Tolu-Sed DM | Dextromethorphan Hydrobromide; Guaifenesin | Scherer Laboratories |
| Tossemed | Dextromethorphan Hydrobromide; Guaifenesin | GlaxoSmithKline |
| Touro DM | Dextromethorphan Hydrobromide; Guaifenesin | Dartmouth Pharmaceuticals |